Polycystic Ovary Syndrome: Evidence for Reduced Sensitivity of the Gonadotropin-Releasing Hormone Pulse Generator to Inhibition by Estradiol and Progesterone1
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Plasma LH is commonly elevated in women with the polycystic ovary syndrome (PCOS), but the underlying mechanisms are uncertain. We tested the hypothesis that the elevated LH in part reflects a reduced sensitivity of the hypothalamic GnRH pulse generator to suppression by estradiol (E2) and progesterone (P). In an initial protocol, normal controls (beginning on cycle days 8-10) and women with PCOS were given E2 transdermally and P by vaginal suppository (three times daily), to achieve plasma concentrations similar to those in the midluteal phase of an ovulatory cycle, for 21 days. Blood was obtained at 10-min intervals for 12 h before and on days 5, 10, 20, and 28 (7 days after E2 and P were discontinued). LH pulse amplitude and LH pulse frequency were suppressed in both PCOS and normal controls, but LH pulse frequency fell more rapidly in controls and was lower by day 10 (P < 0.05). Based on this time course a dose-response study was performed, in which E2 in constant dosage and varying concentrations of P were administered for 7 days. Pulsatile LH release was appraised on days 1 and 7. The frequency of LH pulse secretion was reduced in controls and was lower than that in patients with PCOS on day 7 (P < 0.0001). Plasma P concentrations of 13-15 ng/mL suppressed LH pulse frequency to a similar degree in PCOS and controls. In contrast, lower concentrations (P < 10 ng/mL) were more effective in suppressing GnRH/LH pulse frequency in controls (by > 45% of basal) than in PCOS (< 40%; P < 0.01). The data indicate that E2 and P can inhibit the activity of the hypothalamic GnRH pulse generator in women with PCOS. However, higher plasma concentrations of P were required to reduce GnRH/LH pulse frequency in PCOS compared to controls, suggesting an insensitivity of the GnRH pulse generator to suppression by E2 and P. These results suggest that an abnormality in the regulation of hypothalamic GnRH secretion is present in PCOS and may be a factor in the etiology of the disorder in adolescence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When developing female embryos are exposed to relatively high levels of testosterone—such as in females who develop PCOS—many aspects of HPG activity are affected. Hypothalamic sensitivity to steroid‐induced negative feedback is reduced, resulting in an increased frequency and amplitude of gonadotropin‐releasing hormone (GnRH) and luteinizing hormone (LH) pulses with corresponding increases in LH”
From Endometriosis and polycystic ovary syndrome are diametric disorders (2021) · cites this paper as Pastor et al., 1998
Citations
Cites
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121
Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection
Veldhuis, J. D., & Johnson, M. L. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.250.4.e486 · Cited by 861 · cited 1×
“Data are presented as the mean 6 se. The number of LH pulses and pulse amplitude were measured by the computer algorithm Cluster ( 32 ), using parameters of threshold change corresponding to a t statistic of 2.45 for both the peak upstroke and the peak downstroke.”
MethodInfluentialNestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743
WILDT, L., HÄUSLER, A., MARSHALL, G., HUTCHISON, J. S., PLANT, T. M., BELCHETZ, P. E., & KNOBIL, E. (1981) · Endocrinology · doi:10.1210/endo-109-2-376 · Cited by 684
BARBIERI, R. L., MAKRIS, A., RANDALL, R. W., DANIELS, G., KISTNER, R. W., & RYAN, K. J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-904 · Cited by 630 · cited 1×
“The fall in plasma LH after reduction of insulin in some studies may reflect the coexistent reduction in plasma androgen levels due to reduced enhancement of ovarian androgen secretion by insulin ( 53 , 54).”
BackgroundCharacterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar, R., Judd, H. L., Yen, S. S., Rakoff, J., Vandenberg, G., & Naftolin, F. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108400 · Cited by 622
Dunaif, A., Scott, D., Finegood, D., Quintana, B., & Whitcomb, R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784087 · Cited by 524
EHRMAN, D. A., BARNES, R. B., & ROSENFIELD, R. L. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-322 · Cited by 502
Taylor, A. E., McCourt, B., Martin, K. A., Anderson, E. J., Adams, J. M., Schoenfeld, D., & Hall, J. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4105 · Cited by 494
FILICORI, M., SANTORO, N., MERRIAM, G. R., & CROWLEY, W. F. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-6-1136 · Cited by 489
Morales, A. J. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.2854 · Cited by 455
WALDSTREICHER, J., SANTORO, N. F., HALL, J. E., FILICORI, M., & CROWLEY, W. F. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-165 · Cited by 407
YEN, S. S. C., VELA, P., & RANKIN, J. (1970) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-30-4-435 · Cited by 389
ADASHI, E. Y., HSUEH, A. J. W., & YEN, S. S. C. (1981) · Endocrinology · doi:10.1210/endo-108-4-1441 · Cited by 366
HAISENLEDER, D. J., DALKIN, A. C., ORTOLANO, G. A., MARSHALL, J. C., & SHUPNIK, M. A. (1991) · Endocrinology · doi:10.1210/endo-128-1-509 · Cited by 355
Self-citationNESTLER, J. E., BARLASCINI, C. O., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., CLORE, J. N., & BLACKARD, W. G. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-6-1027 · Cited by 338
Ehrmann, D. A., Cavaghan, M. K., Imperial, J., Sturis, J., Rosenfield, R. L., & Polonsky, K. S. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3722 · Cited by 336
DALKIN, A. C., HAISENLEDER, D. J., ORTOLANO, G. A., ELLIS, T. R., & MARSHALL, J. C. (1989) · Endocrinology · doi:10.1210/endo-125-2-917 · Cited by 329
Self-citationProgesterone Modulation of Pulsatile Luteinizing Hormone Secretion in Normal Women*
SOULES, M. R., STEINER, R. A., CLIFTON, D. K., COHEN, N. L., AKSEL, S., & BREMNER, W. J. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-2-378 · Cited by 319
Barnes, R. B., Rosenfield, R. L., Ehrmann, D. A., Cara, J. F., Cuttler, L., Levitsky, L. L., & Rosenthal, I. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962325 · Cited by 304 · cited 2×
“Modest or moderate hyperandrogenemia in congenital adrenal hyperplasia (CAH) may be associated with an elevation in serum LH and enhanced responses to GnRH, with restoration toward normal when androgens are reduced by therapy ( 20 ).”
BackgroundChang, R. J., Laufer, L. R., Meldrum, D. R., Defazio, J., Lu, J. K. H., Vale, W. W., Rivier, J. E., & Judd, H. L. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-5-897 · Cited by 259 · cited 1×
“The importance of LH stimulation of ovarian androgen secretion is supported by studies using GnRH agonists, in which desensitization of LH secretion is followed by decreases in serum LH, androstenedione, and testosterone (T) ( 12 ).”
BackgroundREAME, N., SAUDER, S. E., KELCH, R. P., & MARSHALL, J. C. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-2-328 · Cited by 258
Self-citationEndocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women
Guzick, D. S., Wing, R., Smith, D., Berga, S. L., & Winters, S. J. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56632-1 · Cited by 246
SPINDER, T., SPIJKSTRA, J. J., VAN DEN TWEEL, J. G., BURGER, C. W., VAN KESSEL, H., HOMPES, P. G. A., & GOOREN, L. J. G. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-1-151 · Cited by 208
Dunaif, A., & Graf, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113864 · Cited by 204 · cited 1×
“In women with PCOS, acute elevation of insulin during a hyperinsulinemic euglycemic clamp did not alter plasma gonadotropin levels ( 52 ).”
BackgroundSERUM STEROIDS AND PITUITARY HORMONES IN FEMALE PUBERTY: A PARTLY LONGITUDINAL STUDY
APTER, D. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02125.x · Cited by 185 · cited 1×
“The pubertal increases in GnRH frequency and amplitude are known to induce some follicular maturation and ovarian steroid secretion, albeit at low levels ( 47 ).”
BackgroundApter, D. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.1.119 · Cited by 178
Can metformin reduce insulin resistance in polycystic ovary syndrome?
Açbay, Ö., & Gündoğdu, S. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58266-1 · Cited by 174
DUNAIF, A., MANDELI, J., FLUHR, H., & DOBRJANSKY, A. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-131 · Cited by 161
Circulating Luteinizing Hormone Pulse Frequency in Women with Polycystic Ovary Syndrome*
KAZER, R. R., KESSEL, B., & YEN, S. S. C. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-2-233 · Cited by 152
APTER, D., & VIHKO, R. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-970 · Cited by 148 · cited 2×
“secretion seen in perimenarchal girls with hyperandrogenism (26), which appears to be a progenitor of anovulation, hyperandrogenism, and reduced fertility seen in adults ( 27 ).”
BackgroundZumoff, B., Freeman, R., Coupey, S., Saenger, P., Markowitz, M., & Kream, J. (1983) · New England Journal of Medicine · doi:10.1056/nejm198311173092002 · Cited by 140 · cited 1×
“In hyperandrogenemic adolescents ( 46 ), daytime LH levels were higher than those in age-matched normal controls.”
BackgroundSPRATT, D. I., FINKELSTEIN, J. S., BUTLER, J. P., BADGER, T. M., & CROWLEY, W. F. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-6-1179 · Cited by 130
NIPPOLDT, T. B., REAME, N. E., KELCH, R. P., & MARSHALL, J. C. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-1-67 · Cited by 119
Self-citationGROSS, K. M., MATSUMOTO, A. M., & BREMNER, W. J. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-4-675 · Cited by 110
Poretsky, L., & Piper, B. (1994) · PubMed · Cited by 102
The Endocrine function of the human ovary
James, V. H. T., Serio, M., & Giusti, G. (1976) · Academic Press Inc. (London) Ltd. eBooks · Cited by 100
Insulin and the Polycystic Ovary Syndrome
Utiger, R. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350909 · Cited by 97
Venturoli, S. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.4.836 · Cited by 97 · cited 2×
“Venturoli studied 13 adolescents over 3 yr and identified individuals with elevated LH, LH pulse frequency, and plasma androgens ( 45 ).”
BackgroundDo Androgens Directly Regulate Gonadotropin Secretion in the Polycystic Ovary SyndromeÓ*
ANDREA, D. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-1-215 · Cited by 85
Enhanced Disparity of Gonadotropin Secretion by Estrone in Women with Poly cystic Ovarian Disease*
CHANG, R. J., MANDEL, F. P., LU, J. K. H., & JUDD, H. L. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-3-490 · Cited by 83 · cited 1×
“Earlier work proposed that the elevated plasma estrone present in PCOS may augment LH responsiveness to GnRH (13), but this view is not supported by studies in which infusion of estrone did not increase plasma LH ( 14 ).”
ResultPORETSKY, L., GLOVER, B., LAUMAS, V., KALIN, M., & DUNAIF, A. (1988) · Endocrinology · doi:10.1210/endo-122-2-581 · Cited by 80
Increased luteinizing hormone and alpha-subunit secretion in women with hyperandrogenic anovulation
Berga, S. L. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.4.895 · Cited by 72
DUNAIF, A., SCULLY, R. E., ANDERSEN, R. N., CHAPIN, D. S., & CROWLEY, W. F. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-389 · Cited by 71
Acute modulation of the hypothalamic-pituitary axis by intravenous testosterone in normal women
Serafini, P. C., Silva, P. D., Paulson, R. J., Elkind-Hirsch, K. E., Hernandez, M., & Løbo, R. A. (1986) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(86)90161-4 · Cited by 70
Christman, G. M., Randolph, J. F., Kelch, R. P., & Marshall, J. C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-6-1278 · Cited by 68
Self-citationLøbo, R. A., & Goebelsmann, U. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)32379-1 · Cited by 55
Steroid Effects on the Secretory Modalities of Gonadotropin-Releasing Hormone Release*
MELROSE, P., & GROSS, L. (1987) · Endocrinology · doi:10.1210/endo-121-1-190 · Cited by 44
Soules, M. R., Clifton, D. K., Bremner, W. J., & Steiner, R. A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-3-457 · Cited by 40
Is changing hypothalamic activity important for control of ovulation?
Clayton, R. N., Royston, J. P., Chapman, J., Wilson, M., Obhrai, M., Sawers, R. S., & Lynch, S. S. (1987) · BMJ · doi:10.1136/bmj.295.6589.7 · Cited by 39 · cited 1×
“In normal women LH pulse frequency is suppressed during the luteal phase of anovulatory cycles ( 43 ), suggesting that low concentrations of P (1‐2 ng/mL) may be adequate to activate this hypothalamic mechanism.”
BackgroundSustained Effects of Opioid Antagonism During the Normal Human Luteal Phase*
GINDOFF, P. R., JEWELEWICZ, R., HEMBREE, W., WARDLAW, S., & FERIN, M. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-5-1000 · Cited by 37
Buckler, H. M., PHILLIPS, S. E., CAMERON, I. T., Healy, D. L., & Burger, H. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-2-300 · Cited by 29
Sir‐Petermann, T., Rabenbauer, B., & Wildt, L. (1993) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137938 · Cited by 20
Frank, S. J. (1995) · Cited by 13
Cited by
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Self-citationThe Insulin-Related Ovarian Regulatory System in Health and Disease
Poretsky, L., Cataldo, N. A., Rosenwaks, Z., & Giudice, L. C. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0374 · Cited by 818
Lehman, M. N., Coolen, L. M., & Goodman, R. L. (2010) · Endocrinology · doi:10.1210/en.2010-0022 · Cited by 768
“Kisspeptin antagonists (99) may therefore represent a potential clinical treatment for PCOS and other disorders where pulse frequency is elevated (90, 100).”
BackgroundMcCartney, C. R., & Marshall, J. C. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1514916 · Cited by 581
“however, in the polycystic ovary syndrome, the GnRH pulse generator is relatively resistant to the negative feedback effects of progesterone.(3) This resistance to progesterone negative feedback appears to be mediated by androgen excess (since it is reversed by the androgen-receptor blocker flutamide).”
BackgroundSelf-citation
Metadata
- Authors
- Pastor, C. L., Griffin-Korf, M. L., Aloi, J. A., Evans, W. S., & Marshall, J. C.
- Affiliations
- University of Virginia (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1998-02
- Volume
- 83
- Issue
- 2
- Pages
- 582-590
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2122612739
- Cited by
- 263
- References
- 54
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 10 · 2023: 8 · 2022: 15 · 2021: 12 · 2020: 14 · 2019: 20 · 2018: 9 · 2017: 10 · 2016: 8 · 2015: 12 · 2014: 11 · 2013: 12 · 2012: 6
- FWCI
- 7.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hd016000-18)
- National Center for Research Resources (M01RR000847, M01-RR 00847)
- NIH Clinical Center
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30 HD28934, R01-HD-16000, P30HD028934)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, gonadotropin-releasing hormone, LH pulse frequency, LH pulse amplitude, estradiol, progesterone, hypothalamic-pituitary-gonadal axis, LH secretion regulation, transdermal estradiol, vaginal progesterone
- MeSH terms
- Adult, Dose-Response Relationship, Drug, Estradiol, Female, Follicle Stimulating Hormone, Humans, Hypothalamus, Kinetics, Luteinizing Hormone, Gonadotropin-Releasing Hormone, Periodicity, Polycystic Ovary Syndrome, Progesterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.